VEGF-mediated angiogenesis and vascularization of a fumarate-crosslinked polycaprolactone (PCLF) scaffold

被引:32
|
作者
Wagner, Eric R. [1 ]
Parry, Joshua [1 ]
Dadsetan, Mahrokh [1 ]
Bravo, Dalibel [1 ]
Riester, Scott M. [1 ]
Van Wijnen, Andre J. [1 ]
Yaszemski, Michael J. [1 ]
Kakar, Sanjeev [1 ]
机构
[1] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA
关键词
PCLF; Polymer; scaffolds; tissue engineering; VEGF; vascular; vascularization; ENDOTHELIAL GROWTH-FACTOR; POLY(EPSILON-CAPROLACTONE FUMARATE); BONE-FORMATION; IN-VITRO; POLY(CAPROLACTONE FUMARATE); DELIVERY; GLYCOL; REVASCULARIZATION; MICROSPHERES; NETWORKS;
D O I
10.1080/03008207.2018.1424145
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Purpose: Revascularization of natural and synthetic scaffolds is a critical part of the scaffold's incorporation and tissue ingrowth. Our goals were to create a biocompatible polymer scaffold with 3D-printing technology, capable of sustaining vascularization and tissue ingrowth. Methods: We synthesized biodegradable polycaprolactone fumarate (PCLF) scaffolds to allow tissue ingrowth via large interconnected pores. The scaffolds were prepared with Poly(lactic-co-glycolic acid)(PLGA) microspheres seeded with or without different growth factors including VEGF,FGF-2, and/or BMP-2. Scaffolds were implanted into the subcutaneous tissues of rats before undergoing histologic and microCT angiographic analysis. Results: At harvest after 12 weeks, scaffolds had tissue infiltrating into their pores without signs of scar tissue formation, fibrous capsule formation, or immune responses against PCLF. Histology for M1/M2 macrophage phenotypes confirmed that there were no overt signs of immune responses. Both microCT angiography and histologic analysis demonstrated marked tissue and vessel ingrowth throughout the pores traversing the body of the scaffolds. Scaffolds seeded with microspheres containing VEGF or VEGF with either BMP-2 or FGF-2 had significantly higher vascular ingrowth and vessel penetration than controls. All VEGF-augmented scaffolds were positive for Factor-VIII and exhibited collagen tissue infiltration throughout the pores. Furthermore, scaffolds with VEGF and BMP-2 had high levels of mineral deposition throughout the scaffold that are attributable to BMP-2. Conclusions: PCLF polymer scaffold can be utilized as a framework for vascular ingrowth and regeneration of multiple types of tissues. This novel scaffold material has promise in tissue regeneration across all types of tissues from soft tissue to bone.
引用
收藏
页码:542 / 549
页数:8
相关论文
共 50 条
  • [31] PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
    Aljada, Ahmad
    O'Connor, Laura
    Fu, Yu-Yen
    Mousa, Shaker A.
    ANGIOGENESIS, 2008, 11 (04) : 361 - 367
  • [32] PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
    Ahmad Aljada
    Laura O’Connor
    Yu-Yen Fu
    Shaker A. Mousa
    Angiogenesis, 2008, 11 : 361 - 367
  • [33] Erratum to: Telomeres and Tissue Engineering: The Potential Roles of TERT in VEGF-mediated Angiogenesis
    Fernando P. Hartwig
    Fernanda Nedel
    Tiago V. Collares
    Sandra B. C. Tarquinio
    Jacques E. Nör
    Flávio F. Demarco
    Stem Cell Reviews and Reports, 2013, 9 : 740 - 740
  • [34] Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles
    G Korpanty
    S Chen
    R V Shohet
    J Ding
    B Yang
    P A Frenkel
    P A Grayburn
    Gene Therapy, 2005, 12 : 1305 - 1312
  • [35] tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis
    Aaron M. Savage
    Sathishkumar Kurusamy
    Yan Chen
    Zhen Jiang
    Karishma Chhabria
    Ryan B. MacDonald
    Hyejeong R. Kim
    Heather L. Wilson
    Fredericus J. M. van Eeden
    Angel L. Armesilla
    Timothy J. A. Chico
    Robert N. Wilkinson
    Nature Communications, 10
  • [36] tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis
    Savage, Aaron M.
    Kurusamy, Sathishkumar
    Chen, Yan
    Jiang, Zhen
    Chhabria, Karishma
    MacDonald, Ryan B.
    Kim, Hyejeong R.
    Wilson, Heather L.
    van Eeden, Fredericus J. M.
    Armesilla, Angel L.
    Chico, Timothy J. A.
    Wilkinson, Robert N.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [37] Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction
    Lee, Yoon-Jin
    Lee, Hae-Jun
    Choi, Seo-hyun
    Jin, Yeung Bae
    An, Ho Jung
    Kang, Jin-Hyoung
    Yoon, Sam S.
    Lee, Yun-Sil
    ANGIOGENESIS, 2012, 15 (02) : 229 - 242
  • [38] A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis
    Wang, Z.
    Perez, M.
    Caja, S.
    Melino, G.
    Johnson, T. S.
    Lindfors, K.
    Griffin, M.
    CELL DEATH & DISEASE, 2013, 4 : e808 - e808
  • [39] Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
    Gammons, M. V.
    Lucas, R.
    Dean, R.
    Coupland, S. E.
    Oltean, S.
    Bates, D. O.
    BRITISH JOURNAL OF CANCER, 2014, 111 (03) : 477 - 485
  • [40] VEGF-Mediated angiogenesis improves in vivo regional compliance in chronically injured rabbit myocardium
    Hueman, MT
    Atkins, BZ
    Hutcheson, KA
    Meuchel, JM
    Cottman, MJ
    Annex, BH
    Glower, DD
    Taylor, DA
    CIRCULATION, 1999, 100 (18) : 838 - 838